Yüklüyor......
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
BACKGROUND: The development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and developed ghost cell glaucoma and analyzed the pot...
Kaydedildi:
| Yayımlandı: | BMC Ophthalmol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161240/ https://ncbi.nlm.nih.gov/pubmed/32295566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01422-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|